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Background: Bacterial spores have been utilized as platforms for protein display. The best studied display systems
are based on Bacillus subtilis spores in which several coat proteins have successfully been used as anchors for
heterologous protein. Increasing knowledge about spore coat structure enables selection of new anchor proteins
such as CotZ and CgeA. Here we describe a system of vectors for display of proteins on the surface of B. subtilis
spores.
Results: We have designed and constructed a set of 16 vectors for ectopic integration which can be used for spore
surface display of heterologous proteins. There is a selection of five coat proteins: CotB, CotC, CotG, CotZ and CgeA
which can be used for construction of fusions. Three of these (CotB, CotC and CotG) enable obtaining N-terminal
and C-terminal fusions and other two (CotZ and CgeA) are designed to produce C-terminal fusions only. All the
vectors enable introduction of an additional peptide linker between anchor and displayed protein to enhance
surface display. As a selection marker trophic genes are used. Additionally we describe an example application of
presented vector system to display CagA protein of Helicobacter pylori in fusion with CgeA spore coat protein.
Conclusions: Described system of vectors is a versatile tool for display of heterologous proteins on the surface of
B. subtilis spores. Such recombinant spores can be further used as for example biocatalysts or antigen-carriers in
vaccine formulations. The lack of antibiotic resistance genes in the system makes such spores an interesting option
for applications in which a possible release to the environment can occur.
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The targeting and anchoring of heterologous proteins
and peptides to the outer surface of bacteriophages and
cells is becoming a tool for research in the fields of
microbiology, molecular biology or vaccinology, as well
as is utilized in the biotechnological industry. This ap-
proach is based on the idea of using naturally occurring
surface proteins as an anchor for targeting proteins of
interest, also called passenger proteins. Such recombin-
ant phages or cells can be used in many applications, to
mention only a few examples, such as vaccine vehicles,
carriers of active enzymes and antibodies, biosensors
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unless otherwise stated.usage of these systems is connected with the need of the
chimeric protein to cross the cytoplasmic membrane.
Not every chimera is able cross this barrier resulting in
failure of surface display. Most of these limitations can
be overcome by using bacterial endospores. Classic ex-
amples of spore forming microorganisms are bacteria
from genus Bacillus. Formation of endospores is a strat-
egy used by these bacteria to survive unfavorable and
growth-restricting conditions. Bacillus is well known aer-
obic bacterium widely used for production of industrial
proteins. It is classified as a GRAS organism (generally
recognized as safe), possesses low trophic requirements
and serves as a model Gram-positive microorganism. One
of the main advantages of Bacillus spores as vehicles for
surface display of proteins is that these structures are
formed inside of mother cell in natural process ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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active in the cytoplasm of bacteria can facilitate proper
folding of the heterologous protein.
The process of sporulation is controlled by a multistep
developmental program starting with formation of polar
septum. Upon formation of asymmetric compartments
the mother cell initiates the engulfment of the forespore,
which upon completion of this process becomes double-
membrane bound structure. As the engulfment proceeds
two external protective layers are built: the cortex, com-
posed of peptidoglycan [5], assembled between the inner
and outer forespore membranes, and the proteinaceous
coat, the outermost spore layer [6,7]. The central part of
the spore is the core, containing partially dehydrated
cytoplasm.
The spore coat is composed of at least 70 individual
proteins, which are produced in the mother cell [8] and
consists of three distinct layers: a lamellar inner coat, a
more coarsely layered outer coat and the crust [9,10].
While five proteins are crucial for proper spore coat for-
mation (SpoIVA, SpoVM, SpoVID, SafA and CotE) and
therefore they are called morphogenetic proteins [11],
another three proteins, CotX, CotY and CotZ, have been
shown to be morphogenes of the crust [11,12].
So far four spore coat proteins have been used for dis-
play of enzymes or antigens in spore based vaccines.
These are CotB, CotC, CotG and CotX. All of them are
located in the outermost layer of the coat. CotB protein
has been used for display of C-terminal part of Clostrid-
ium tetani toxin [13], 1b-3 and 4 domains of the Pro-
tective Antigen of Bacillus anthracis [14] and subunit A
of Helicobacter acinonychis urease [15]. This last one
has also been displayed using CotC and CotG proteins.
CotC served as an anchor for such proteins as teugmen-
tal protein of Clonorchis sinensis [14] or human serum
albumin [16]. CotG protein has been used for display of
GFP [17] or heterologous enzymes [18,19]. Recently, a
crust protein CotZ has been shown to be a good candi-
date as a new anchor protein useful in spore surface dis-
play [20].
Here we present a system of 16 integration vectors
which can be used for display of heterologous proteins
on the spore surface utilizing CotB, CotC, CotG, CotZ
or CgeA spore coat proteins. Vectors are prepared in the
way enabling for cloning a gene of interest to at the N-
or C-terminus of a gene coding for spore coat protein
with an optional peptide linker. Each vector harbors
proper trophic gene, which ensures genetic stability and
selection for appropriate recombinant strains. Lack of
antibiotic resistance genes makes the use of such vector
system safe in case of applications in which prepared re-
combinant spores could enter the environment. Such
system could be easily used for preparation of spore-
based vaccines or as biocatalysts.Results and discussion
The design of pCot vectors
The prototype vector of the pCot set has the following
properties. (i) It cannot replicate in B. subtilis but carries
ColE1 replication sequences and a β-lactamase gene for
amplification in E. coli. (ii) The cot/cgeA gene is cloned
along with its original promoter to ensure proper ex-
pression of obtained fusion protein. Depending on the
designation of the vector a cloning site is introduced
either at the N- or C-terminus of the cot gene. (iii) Gen-
etic stability and selection of recombinant strains is pos-
sible due to presence of selection marker – a trophic
gene cassette enabling for complementation in recipient
auxotrophic strain. It is worth stressing out that no anti-
biotic resistance gene selectable in B. subtilis is intro-
duced into the vectors. Such design of the system is
especially important for applications in which recombin-
ant spores can be released to the environment. In that
case it prevents from shedding the antibiotic resistant
bacteria. A trophic gene cassette is cloned downstream
of the cot gene to prevent transcription interference. (iv)
The cot/cgeA gene along with trophic gene cassette is
flanked by fragments of non-essential gene to enable ec-
topic integration into the chromosome of recipient
strain.
Five spore coat proteins have been selected as carriers
of heterologous proteins. The usefulness of four proteins
CotB, CotC, CotG and CotZ for such application has
already been shown. Additionally a crust protein CgeA
has also been selected.
In case of well described CotBCG proteins we decided
to prepare four variants of the vectors. Two enable pro-
ducing recombinant protein fused to C-terminus of Cot
protein while the other two are designed for N-terminal
fusions. Each pair consists of one version of vector in
which recombinant protein is linked directly to Cot pro-
tein and the other with short peptide linker (−GGGGS-).
The vectors with cotZ and cgeA genes are designed in a
way enabling for obtaining fusions with heterologous
protein attached to the C-terminus of the coat protein
directly or via alpha-helical linker (−GGGEAAAKGGG-)
[21]. Such set of vectors gives a flexibility in construc-
tion of strains producing recombinant spores. The effi-
ciency of expression and surface display of heterologous
protein depends on its nature. It is known, that in case
of some protein fusions direct link between two partners
may result in fusion instability or aggregation [22,23]. In
case of spore surface display such situation would pre-
vent coat protein-passenger protein fusion from incorp-
oration into the spore coat structure. Linking of
heterologous protein to the coat protein by a linker
might help to solve these problems. A choice of type of
fusion with spore coat protein gives an opportunity to
optimize the display.
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cloned along with its original promoter and ribosome
binding site (RBS). A cot/cgeA gene has no STOP codon
but a multiple cloning site is located right at the end of
the gene or just after the sequence coding for a peptide




































Figure 1 Schematic maps of the cotG vector series. Indicated sites for r
protein to be displayed on the spore surface.with its own STOP codon to ensure proper termination
of translation.
Vectors for N-terminal fusions have a multiple cloning
site inserted in between START codon and the remaining
part of a cot gene. In variants with linkers a linker coding




































estriction enzymes are available for cloning of a gene encoding a
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portant to verify, that a gene of interest is cloned in frame
of the cot gene translation and it has no STOP codon.
Ectopic integration loci are selected as follows: pCotB,
pCotZ and pCgeA vectors – amyE, pCotC vectors –
lacA and pCotG vectors – pyrD. All the loci are non-
essential for growth of B. subtilis in normal conditions
and are commonly used for introducing cloned genes or
constructs into the chromosome of this bacterium. The
use of different integration loci makes the system more
flexible and enables designing a recombinant strains dis-
playing on the spore surface three different fusions at
the same time.
The following genes are used as selection markers in the
vector system: pCotB – thrC, pCotC, pCotZ, pCgeA –
trpC and pCotG – lysA. Recipient strains compatible with
these vectors should be the auxotrophs for appropriate
amino acids. The auxotrophy can be achieved by inacti-
vation, deletion or complete knockout [24] of the gene
used for selection. Selection of recombinant strains
upon transformation can then be done using plates
with minimal medium lacking threonine, tryptophan or
lysine. As an example vectors of pCotG series are





Figure 2 The cotG vector series. A – 5’ and 3’ end of cotG gene. B – mu
peptide linker present in pCotG-NL vector. D – multicloning site present in
pCotG-CL vector. Colour labels: orange – ribosome binding site of cotG, gre
red – stop codon.Construction of pCgeA-CagA vectors
To test the system we have prepared two vectors for dis-
play of a fragment of Helicobacter pylori CagA protein
(cytotoxic-associated gene A) in fusion with C-terminal
end of CgeA protein. The heterologous part of the fu-
sion encompassed 83 amino acids (residues 1146 to
1222) of CagA and was selected from the most immuno-
genic regions of this protein as designated by Antigen
program (a part of EMBOSS package; http://emboss.
sourceforge.net/). One vector enabled production of dir-
ect fusion of CgeA and CagA fragment, while in the
other the heterologous part was connected via alpha-
helical linker. Obtained plasmid were named pAV05
(cgeA-cagA) and pAV03 (cgeA-linker-cagA) and used for
transformation of Bacillus subtilis strain 168. Laboratory
strain 168 is an auxotroph for tryptophan due to muta-
tion in trpC gene. The presence of functional trpC gene
(cloned from B. subtilis 3610) within the region, which is
integrated into the amyE locus along with cgeA-cagA fu-
sion upon successful recombination enabled us to select
prototrophic recombinant strains (Figure 3).
Both strains and their isogenic parental strain 168
showed comparable sporulation and germination effi-
ciencies and their spores were equally resistant tolticloning site present in the pCotG-N vector. C – multicloning site and
pCotG-C vector. E – peptide linker and multicloning site present in
en – start codon, blue – multicloning site, violet – peptide linker,
BAV05 168
Figure 3 Growth of recombinant strain BAV05 and wild-type
strain 168 on minimal plates lacking tryptophan.
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fore, limited to the spore properties that we have analyzed,
the presence of CgeA-CagA and CgeA-linker-CagA fu-
sions did not affect spore structure or functionality.Spore coat expression
The localization of fusion proteins on the spore coat was
tested by western blotting with anti-CgeA and anti-
CagA antibodies. The analysis of spore coat proteins
purified from the wild type and recombinant strains
BAV05 carrying fusion CgeA-CagA revealed the pres-











Figure 4 Western blotting analysis of expression of the cgeA-cagA fus
western blotting with anti-CgeA (panel A) or anti-CagA (panel B) antibod
(inactivation of cgeA) (lane 2), the BAV05 (fusion CgeA-CagA) (lane 3) and t
A and B was loaded with 20 μg of total proteins.CgeA- and CagA-specific antibodies (Figure 4). In case
of strain BAV07 (CgeA-linker-CagA) we observed an
about 24-kDa band, which also reacted with both types
of antibodies (Figure 4). Calculated molecular masses of
fusion proteins are 22.8 kDa for CgeA-CagA and
23.6 kDa for fusion with linker and correspond well with
the results obtained in the western blotting. CgeA-
specific antibodies produced an about 14-kDa band cor-
responding to native CgeA protein, as well as several
bands of higher molecular masses, which most probably
represent multimers of CgeA protein since they cannot
be visualised in hybridizations with spore coat proteins
isolated from the strain BAV08 with inactivation of cgeA
gene (Figure 4A, lane 2).
Surface display
The surface localization of CgeA-CagA (BAV05) and
CgeA-GGGEAAAKGGG-CagA (BAV07) fusion proteins
was analyzed by immunofluorescence microscopy of dor-
mant spores of wild type and recombinant strains using
anti-CgeA and anti-CagA primary antibodies followed by
anti-mouse IgG-Cy3 (Jackson ImmunoResearch Labora-
tories, Inc). We observed a fluorescent signal around puri-
fied dormant spores of both BAV05 and BAV07 strains
(Figure 5). These results indicate that both fusion proteins
are present on the spore coat surface and are available for
antibody binding. It is worth notifying, that fluorescent
signal observed in case of BAV07 spores is stronger than
in case of BAV05, what clearly suggest, that anchoring of
CagA to CgeA protein via helical linker increases the effi-
ciency of surface display of heterologous protein.
Conclusions
Presented set of vectors is a versatile system for spore
surface display of heterologous proteins. Since the1 3 4
ion gene. Spore coat proteins were extracted and analysed by
ies. Spore coat proteins from spores of the 168 (lane 1), the BAV08





Figure 5 Localisation of fusion proteins as assessed by immunofluorescence microscopy. Purified, free spores of wild type strain 168,
BAV05 (CgeA-CagA), BAV07 (CgeA-linker-CagA) were visualised by phase contrast (PC) and immunofluorescence (IF) microscopy. The spores were
incubated with mouse anti-CagA, followed by anti-mouse IgG-Cy3 conjugates. The same exposure time was used for all IF images. Black and
white scale bars – 1 μm.
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depends on its nature, as well as, the properties of ob-
tained fusions it may be necessary to design a panel of
plasmids with different spore coat proteins as anchors
including or not a peptide linker to enhance the display.
A variety vectors included in the presented system facili-
tates such optimization. It is also important to point out,
that all Cot coat proteins used in the system has already
successfully been utilized in such applications. Addition-
ally, another coat protein, CgeA, turned out to be useful
for presentation of heterologous proteins.
Methods
Bacterial strains and transformation
Plasmid amplifications for nucleotide sequencing and sub-
cloning experiments were performed with Escherichia coli
strains DH5α [25] or BL21 (New England Biolabs, USA).
Bacterial strains were transformed by previously described
procedures: CaCl2-mediated transformation of E. coli
competent cells [26] and transformation of B. subtilis [27].
Bacillus subtilis 168 was used for construction of recom-
binant strains.Construction of gene fusions
DNA coding for coat proteins was PCR amplified using
the B. subtilis 168 chromosome as a template and oligonu-
cleotides listed in Additional file 1: Table S1 as primers.
Amplification products were cloned into the vectors listed
in the Additional file 1: Table S1. In case of vectors for N-
terminal fusions promoter regions of corresponding coat
protein genes were separately PCR amplified using oligo-
nucleotides listed in Additional file 1: Table S1 as primers
and cloned into appropriate vectors. The DNA coding for
lysA and thrC trophic genes were PCR amplified using ap-
propriate oligonucleotides as primers (Additional file 1:
Table S1) and chromosomal DNA of B. subtilis strain 168.
The trpC gene was amplified with using chromosomal
DNA of B. subtilis 3610 strain with addition of the prrnO
promoter sequence included in the primers. Obtained PCR
fragments harboring a trophic gene along with the pro-
moter were cloned into the proper plasmids (Additional
file 1: Table S1). Where necessary the MCS was introduced
by cloning a DNA fragment obtained upon annealing of
appropriate oligonucleotides (Additional file 1: Table S1).
The pCotB vector set was constructed using synthetic gene
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vectors is presented in Table 1.
For construction of H. pylori CagA-presenting spores
following plasmid was prepared. A 227 bp DNA frag-
ment encoding part of CagA was PCR amplified using
Helicobacter pylori NCTC 11637 chromosome as a tem-
plate and oligonucleotides cagA-F and cagA-R (Table 2)
as primers. The PCR product was sequentially digested
with BamHI and KpnI and cloned in frame to the 3’ end
of the cgeA gene carried by plasmid pCgeA-C or pCgeA-
CL yielding plasmids pAV05 and pAV03.
Chromosomal integration
Appropriate plasmids were linearized by digestion with a
single cutting restriction enzyme. Linearized DNA was
used to transform competent cells of the B. subtilis strain
168. The bacteria were plated on solidified Belitzky min-
imal medium without tryptophan [28]. Prototrophic clones
were the result of a double-crossover recombination event,
resulting in the interruption of the non-essential amyE
gene on the B. subtilis chromosome. Several prototrophic
clones were tested by PCR using chromosomal DNA as a
template and oligonucleotides AmyS and AmyA [29] to
prime the reaction. Selected clones were called BAV05
(CgeA-CagA) and BAV07 (CgeA-linker-CagA) and stored
for further research.
Construction of the strain with inactivation of the cgeA
gene
A 316 bp fragment of the cgeA gene was PCR amplified
using chromosomal DNA of B. subtilis strain 168 as a
template and oligonucleotides i-cgeA-F and i-cgeA-RTable 1 List of vectors in the system
Name Coat gene and type of fusion
pCotB-N cotB N-terminal
pCotB-NL cotB N-terminal + linker
pCotB-C cotB C-terminal
pCotB-CL cotB C-terminal + linker
pCotC-N cotC N-terminal
pCotC-NL cotC N-terminal + linker
pCotC-C cotC C-terminal
pCotC-CL cotC C-terminal + linker
pCotG-N cotG N-terminal
pCotG-NL cotG N-terminal + linker
pCotG-C cotG C-terminal
pCotG-CL cotG C-terminal + linker
pCotZ-C cotZ C-terminal
pCotZ-CL cotZ C-terminal + linker
pCgeA-C cgeA C-terminal
pCgeA-CL cgeA C-terminal + linker(Table 2) as primes. The obtained PCR product was
digested with enzymes HindIII and BamHI and cloned into
the pMUTIN4 vector [30]. The resulting plasmid, pAGW6,
was verified by restriction analysis and used for transform-
ation of B. subtilis strain 168. Obtained erythromycin-
resistant colonies were the result of single crossing-over
recombination event leading to the insertion of the plasmid
into the chromosome of recipient strain. Selected colonies
were PCR-verified for the correctness of the cgeA gene in-
activation. The resulting strain was called BAV08 and
stored for further research.
Preparation of spores
Sporulation was induced by the exhaustion method in
Difco sporulation medium (DSM) as described elsewhere
[31]. Sporulating cultures were harvested 24 h after the
initiation of sporulation and purified using a lysozyme
treatment to break up any residual sporangial cells,
followed by washing steps in 1 M NaCl, 1 M KCl and
water (twice each), as described by Nicholson & Setlow
[31]. PMSF (0.05 M) was included to inhibit proteolysis.
After the final suspension in water, spores were treated
at 65°C for 1 h to kill any residual cells. The spore sus-
pension was titrated immediately for determination of
c.f.u./ml before freezing at −22°C. Using this method, we
could reliably produce 6 × 1010 spores in 1 liter of DSM
culture.
Extraction of spore coat proteins
Spore coat proteins were extracted from 50 μl of a suspen-
sions of spores at high density (1 × 1010 spores per ml)

















Table 2 Oligonucleotides list









In bold are the recognition sites for the restriction enzymes indicated in the table. Oligonucleotides used for construction of vectors of the system are listed in
Additional file 1: Table S1.
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SDS-polyacrylamide gel electrophoresis (PAGE) and for
concentration by two independent methods: the Pierce
BCA Protein Assay (Pierce, USA) and the BioRad DC Pro-
tein Assay kit (Bio-Rad, USA).
Western blotting analyses
Extracted proteins were separated in 12% denaturing
polyacrylamide gels, electrotransferred onto a nitrocellu-
lose filter (Roti-NC; ROTH) and used for Western blot-
ting by standard procedures. Western blot filters were
visualized by developing with BCIP/NBT according to
the manufacturer’s instructions (Thermo Scientific).
Immunofluorescence microscopy
Samples were fixed directly in the medium as described
by Harry et al. [33], with the following modifications:
spores were suspended in TE buffer [20 mM Tris/HCl
(pH 7.5), 10 mM EDTA] containing 2 mg lysozyme ml.
After 3 min of incubation, three washes in PBS (pH 7.4)
were performed before blocking with 3% skimmed milk
in PBS for 30 min at room temperature and washing an-
other three times in PBS. Samples were incubated over-
night at 4°C with mouse anti-CagA antibody, washed
three times and then incubated with anti-mouse Cy3-
conjugated IgG (Jackson ImmunoResearch Laboratories)
overnight at 4°C. After three washes with PBS, samples
were loaded on microscope slides previously coated with
poly-L-lysine (Sigma). The coverslips were mounted on a
microscope slide and viewed using a Zeiss Axioplan fluor-
escence microscope with the same exposure time for all
samples. Images were captured using a camera connected
to the microscope, processed with Corel Photo-Paint soft-
ware and saved in TIFF format.
Purification of CgeA and CagA and antibody production
The cgeA gene of B. subtilis was PCR amplified using
chromosomal DNA as a template and oligonucleotides
pRSETAcgeA-F and pRSETAcgeA-R (Table 2) as primes.
The obtained PCR product of 415 bp was digested withenzymes EcoRI and BamHI and cloned into the com-
mercial vector pRSETA (Invitrogene). The resulting
plasmid, pAN17, was verified by restriction analysis and
nucleotide sequencing. The protein was purified and
used for antibody production following method de-
scribed previously [21].
The fragment of cagA gene of H. pylori was PCR ampli-
fied using chromosomal DNA as a template and oligonu-
cleotides pLATE52cagA-F and pLATE52cagA-R (Table 2)
as primes. The obtained PCR product of 261 bp was
cloned into the commercial vector pLATE 52 (Thermo
Scientific, Lithuania) using aLICator Ligation Independent
Cloning and Expression System (Thermo Scientific). The
resulting plasmid, pKH143, was verified by restriction ana-
lysis and nucleotide sequencing. The protein was purified
and used for antibody production following method de-
scribed previously [21].Ethics statement
This study was carried out in strict accordance with the
recommendations in the institutional and national
guidelines for animal care and use. The protocol was ap-
proved by the Committee on the Ethics of Animal
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